A. Ohwada et al., DNA vaccination against HuD antigen elicits antitumor activity in a small-cell lung cancer murine model, AM J RESP C, 21(1), 1999, pp. 37-43
Citations number
30
Categorie Soggetti
da verificare
Journal title
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
There is a clinically significant correlation between the presence of an an
tibody against the paraneoplastic encephalomyelitis antigen HuD and the lim
itation of tumor spread in patients with small-cell lung cancer (SCLC). Thi
s suggests that HuD is a possible target molecule for antitumor immunothera
py against SCLC. We have hypothesized that anti-HuD immunity suppresses ill
vivo growth of HuD-expressing tumor cells. In this study, Colon 26, a muri
ne adenocarcinoma cell line, stably transfected with the HuD gene (Colon 26
/HuD cell) was used as a target cell, and the immunity against HuD was evok
ed by intramuscular injection of a HuD-expressing plasmid, a technique of D
NA vaccination previously used in BALB/c mice. Colon 26/HuD cells were inje
cted subcutaneously and tumor size was calculated as a product of width and
length. Antitumor activity was investigated by using two different lots of
Colon26/HuD cells in two protocols: Protocol 1, in which either Colon 26/H
uD or Colon 26 cells were injected in each side, and Protocol 2, in which C
olon 26/HuD cells alone were injected. The size of Colon 26/HuD tumors obta
ined from mice vaccinated with HuD-expressing plasmid was significantly sma
ller than those from negative control plasmid-vaccinated mice (86.6 +/- 29.
9 versus 195.3 +/- 48.1 mm(2), P < 0.05 in Protocol 1; 107.7 +/- 12.8 versu
s 156.6 +/- 22.8 mm(2), P < 0.05 in Protocol 2). Moreover, the de novo DNA
synthesis of spleen cells obtained from HuD-vaccinated mice was significant
ly enhanced. In addition, anti-HuD antibody was found in individual sera ob
tained from HuD-vaccinated mice. DNA vaccination with mouse HuD antigen sup
pressed HuD-expressing tumor growth in a murine SCLC model.